News

Multicenter ACTIVATE II Study to Enroll up to 50 Patients in Australia

AccuRhythm AI algorithms shown to reduce false alerts by 84% 

ACC Asia Conference’s innovative educational experience demonstrates era of global collaboration

Cedars-Sinai Investigators Found It Also Reduced Scarred Heart Tissue in Animals

Non-tapered metal-alloy support catheter platform receives FDA clearance for use in coronary and peripheral vasculature. Transit Scientific now has one of the largest platforms of FDA cleared microcatheters in the industry.

Study further validates transcatheter edge-to-edge strategy to treat tricuspid regurgitation

By studying the gut microbes of rats, Yang and colleagues discovered that a bacteria known as Coprococcus comes contributes to resistance to ACE inhibitors, one of the primary drug classes used to treat high blood pressure.

The six-letter, seven-shot word game works much like its counterpart, but uses only medical words, no abbreviations, and no brand names. Players can also input non-medical words to help solve the puzzle.

April 6, 2022 — A new study by researchers at Intermountain Healthcare finds that alcohol consumption does not provide additional heart benefits in cardiology patients already being treated with statins. Previously, some observational...

Cordis today announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the Venous Thromboembolism Market. This move signals new chapter of innovation for Cordis.